| Literature DB >> 22149434 |
Stavros Gravas1, Vassilios Tzortzis, Santiago Isorna Martinez de la Riva, Pilar Laguna, Jean de la Rosette.
Abstract
Recent stage migration toward low-risk prostate cancer, overtreatment of biologically insignificant tumors with radical prostatectomy at the additional expense of a non-negligible morbidity and undertreatment of patients improperly selected for active surveillance are the main reasons that have fueled the concept of focal therapy. Optimal selection of patients is the key for the successful implementation of focal therapy. Selection criteria for focal therapy vary widely and depend on clinical, histological and imaging characteristics of the patients that are highlighted in this article. In addition, the rationales, merits and limitations of the available methods for the assessment of potential candidates, the evaluation of treatment efficacy and follow-up of these patients are discussed.Entities:
Mesh:
Year: 2012 PMID: 22149434 DOI: 10.1586/era.11.144
Source DB: PubMed Journal: Expert Rev Anticancer Ther ISSN: 1473-7140 Impact factor: 4.512